WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
Whiteswell has raised €26M across 1 funding round from 1 investor, most recently a Series B round in Dec 2018. Based in Ballybrit, Ireland; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-13 | Series B |
| €26M |
| RA Capital Management |
| View deal → |
